APA (7th ed.) Citation

TL, C., PM, W., R, K., PR, B., GH, R., HN, S., . . . UR, K. (2001). Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse. Blood, 97(2), 572. https://doi.org/10.1182/blood.v97.2.572

Chicago Style (17th ed.) Citation

TL, Carter, Watt PM, Kumar R, Burton PR, Reaman GH, Sather HN, Baker DL, and Kees UR. "Hemizygous P16(INK4A) Deletion in Pediatric Acute Lymphoblastic Leukemia Predicts Independent Risk of Relapse." Blood 97, no. 2 (2001): 572. https://doi.org/10.1182/blood.v97.2.572.

MLA (9th ed.) Citation

TL, Carter, et al. "Hemizygous P16(INK4A) Deletion in Pediatric Acute Lymphoblastic Leukemia Predicts Independent Risk of Relapse." Blood, vol. 97, no. 2, 2001, p. 572, https://doi.org/10.1182/blood.v97.2.572.